Company intelligence / Profile preview

Actipulse Neuroscience

Cambridge, Massachusetts, United Statesactipulseneuroscience.com ↗

Ownership: Private
Employees: ~38
Development stage: Phase 3

Overview

The company’s proprietary non-invasive brain stimulation devices have treated over 10,000 patients as of June 2021. Their hospital-based system has been deployed in over 210 clinics. The at-home version for MDD treatment was entering FDA pivotal trials as of late 2024. Early results suggest comparable efficacy to traditional TMS with improved accessibility and cost-effectiveness.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (Non-Invasive Brain Stimulation)Transcranial magnetic stimulation device (TMS)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

Actipulse Home

Phase 3

Indications: Major Depressive Disorder

1 more asset in the full pipeline.

Request access →

Partnerships

Y Combinator accelerator/funding partner; no major pharma partnerships disclosed.

Beyond the preview

Go deeper on Actipulse Neuroscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actipulse Neuroscience.

Explore the full profile